Peptides Derived from In Vitro and In Vivo Digestion of Human Milk Are Immunomodulatory in THP-1 Human Macrophages
Authors:
- 9 November 2021
- journal article
- research article
- Published by Elsevier in The Journal of Nutrition
- Vol. 152 (1) , 331-342
Abstract
Milk proteins contain many encrypted bioactive peptides. Whether these bioactive peptides are released in the infant intestine and exert immunomodulatory activity remains unknown. This study examined in vitro immunomodulatory activities of peptides from in vitro– and in vivo–digested human milk. Peptides were extracted from in vitro–digested human milk and pooled intestinal samples from 8 infants fed human milk. Peptides extracted from in vitro–digested samples were fractionated. The in vitro effects of these peptides and fractions on the secretion of TNF-α and IL-8 in LPS-treated human immune THP-1 macrophages were evaluated. The significance of differences between in vitro peptide fraction treatment and control on cytokine production was analyzed by t test. LC-MS/MS–based peptidomics was conducted to identify the peptides. The peptides were screened for potential bioactivity using a sequence homology search using the Milk Bioactive Peptide Database (MBPDB). Six fractions of the peptide mixture extracted from the in vitro–digested human milk significantly inhibited TNF-α production by LPS-challenged THP-1 macrophages. Fractions F4, F8, F11, F14, and F17 attenuated IL-8 secretion, and F6/7 and F18 increased IL-8 secretion. Peptides extracted from the pooled in vivo intestinal samples attenuated both TNF-α and IL-8 secretion. There were 266 and 418 peptides identified in the in vitro and in vivo samples, respectively. Among the peptides, 34 and 50 in the in vitro and in vivo samples, respectively, had >80% sequence similarity to bioactive peptides in the MBPDB. Peptides released by in vitro and in vivo infant digestion of human milk were immunomodulatory in human immune cells; fractions F4, F8, and F11 were anti-inflammatory; and F6/7 and F18 were proinflammatory. Thirteen peptides were present in all fractions with anti-inflammatory activity, and 38 peptides were present in all fractions with proinflammatory activity. These peptides potentially contributed to the observed immunomodulatory activity of the peptide mixtures.Keywords
Funding Information
- Pathway to Independence Career (K99/R00)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R00HD079561)
- Gerber Foundation (2017-1586)
- National Institute of Food and Agriculture (2018-67017-27521)
- USDA Multistate Workgroup (W4002)
- Oregon State University
- NIH (1S10OD020111-01)
This publication has 36 references indexed in Scilit:
- Challenges in infant immunity: implications for responses to infection and vaccinesNature Immunology, 2011
- The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived MacrophagesPLOS ONE, 2010
- β-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a μ-opioid pathwayAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Toll-Like Receptor 4 (TLR4)-Deficient Murine Macrophage Cell Line as an In Vitro Assay System To Show TLR4-Independent Signaling ofBacteroides fragilisLipopolysaccharideInfection and Immunity, 2002
- TNF? and the TNF receptor superfamily: Structure-function relationship(s)Microscopy Research and Technique, 2000
- Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative ColitisThe American Journal of Pathology, 1999
- Identification of a phosphopeptide in bovine αs1-casein digest as a factor influencing proliferation and immunoglobulin production in lymphocyte culturesJournal of Dairy Research, 1998
- Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteinsFEBS Letters, 1996
- Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferationClinical and Experimental Immunology, 1991
- Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant.Archives of Disease in Childhood, 1980